vapogenix.com
Vapogenix is developing a new class of superior non-narcotic analgesics that treat pain at its source.
- Stage Product In Development
- Industry Other
- Location Houston, TX, USA
- Currency USD
- Website vapogenix.com
Company Summary
Vapogenix is an innovator of superior medicines for preventing and treating localized pain through transforming approved therapeutics into novel products. Our technology is based on new routes of administration for a class of off-patent drugs not previously used for pain, with broad potential to treat many painful disorders without the side effects of narcotics. Our 1st product is a quick acting topical analgesic for procedural pain
Team
-
Danguole AltmanPresident and CEO
Experienced entrepreneur. Ex-McKinsey. AB Harvard, MBA Yale
-
Heather Giles, Ph.d.Chief Scientific Officer
20+ years drug development experience at GSK. ex-VP Encysive, Ph.D. Pharmacology University of London
-
Terry Farmer, Ph.D.Director, CMC & Analytical Services
10+ yrs industry CMC/Analytical experience, ex-Encysive, Ph.D. UTHSC Biochemistry
-
Clarice Motter, CPACFO
10+ yrs CFO, ex-KPMG, MBA UCLA
Advisors
-
Michael Blaney, JD Blaney & AssociatesLawyerUnconfirmedPKF TexasAccountantUnconfirmed
Previous Investors
-
Pamoja CapitalUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.